Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rifampin

"Rifampin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)


This graph shows the total number of publications written about "Rifampin" by people in Harvard Catalyst Profiles by year, and whether "Rifampin" was a major or minor topic of these publication.
Bar chart showing 160 publications over 25 distinct years, with a maximum of 18 publications in 2018
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.